Record mula sa primary source
Decision-gradePag-apruba ng FDA
Omeros Corporation · Pinahintulutan ng FDA ang Yartemlea (narsoplimab-wuug)
FDA's Purple Book lists BLA 761152 (Yartemlea, narsoplimab-wuug; Omeros Corporation, CDER) as licensed on 2025-12-23.
Mahahalagang fact
- Na-file
- Dis 23, 2025, 12:00 AM
- Kaganapan
- Pag-apruba ng FDA
- Direksyon
- Positibo
- Kumpiyansa
- May source
OMEROmeros